By ETF Desk
Manipal Hospitals, a leading healthcare provider in India, is all set to list its shares on the stock market with its Initial Public Offering (IPO). The IPO, which has been in the pipeline for some time, has generated significant interest among investors, with grey market premium (GMP) signaling a strong opening. As the IPO listing date approaches, investors are eagerly waiting to see how the shares perform on the market.
The GMP, which is the difference between the expected listing price and the current market price, has been trending upwards in recent days. This suggests that investors are confident about the company's prospects and are willing to pay a premium for its shares. However, it is essential to note that GMP is not a foolproof indicator of the stock's performance, and investors should do their own research before making any investment decisions.
The listing of Manipal Hospitals' shares on the stock market is expected to have a significant impact on the healthcare sector in India. As one of the largest private healthcare providers in the country, the company's listing is likely to set a benchmark for other healthcare companies looking to list their shares on the market. Additionally, the listing is expected to provide a boost to the Indian stock market, which has been struggling in recent times.